Genewiz From Azenta Life Sciences Celebrates 25 Years Of Advancing Scientific Discoveries At Genewiz Week Event

FHS
August 22, 2024
10:32 am

GENEWIZ Week 2024 marks 25 years of multiomics solutions, featuring workshops, an awards program, and networking opportunities for the research community.

Ipsen gains global rights to Foreseen Biotechnology’s FS001 ADC

FS001 incorporates a stable and cleavable linker with a potent topoisomerase I inhibitor. Credit: 15Studio/Shutterstock. Ipsen has entered an exclusive global licensing agreement with Foreseen

July 12, 2024

Researchers identify microbial enzyme responsible for making urine yellow

Researchers at the University of Maryland and National Institutes of Health have identified the microbial enzyme responsible for giving urine its yellow hue, according to

January 3, 2024

Fixing the reimbursement and coverage divide between ‘breakthrough’ drugs and medical devices

The Food and Drug Administration designates as “breakthrough” technologies certain drugs and devices. This designation helps expedite the development and review of therapies intended to

July 23, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.